• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Cerner, Truman Medical Center Partner to Launch Remote Patient Monitoring Program for Chronic Conditions

by Fred Pennic 05/17/2017 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Cerner, Truman Medical Center Partner to Launch Remote Patient Monitoring Program for Chronic Conditions

Cerner and Truman Medical Centers (TMC) have teamed up to launch comprehensive disease management programs to engage patients in their health and improve outcomes for groups of individuals with high-risk chronic conditions. Through the initiative, Algorithms configured in Cerner’s HealtheIntent population health management platform identified select groups of TMC’s patient population with conditions like diabetes and chronic heart failure that could benefit from enhanced health monitoring.

To track health conditions and vitals outside of the traditional hospital setting, program participants will receive remote patient monitoring kits with medical devices that are connected to their individual electronic health records. HealtheIntent aggregates and analyzes participant health information and sends automated alerts of concerning data patterns in near real-time to help TMC care teams proactively intervene with essential treatment plans.

After six to nine months, participants’ health metrics will be assessed to determine if their health outcomes have improved. TMC and Cerner will use the results of the pilot to inform the expansion of similar remote patient monitoring programs at TMC and across the health care industry.

“We joined this strategic relationship with Cerner to research and develop opportunities to improve the health of our population, and we are proud to launch this pilot program. Diabetes and chronic heart failure are not only common, life-threatening and costly diseases, they are also extremely preventable. Our goal is to encourage participants to more actively manage their care and provide our care teams with the tools and opportunities to intervene with treatment, ultimately working to positively impact health conditions and prevent readmissions,” said Mitzi Cardenas, senior vice president and chief strategy and information officer, TMC.

 

In October 2015, TMC and Cerner entered into a strategic relationship dedicated to the transformation of health care in Kansas City. The goal of the alignment, named KC one, is to solve the challenges of health care, such as how to lower costs, enhance the quality of care and improve patient safety.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |